M.T.I Prop Funding Program: A New Era in Trading Begins

2025-03-11 M.T.I Prop HaiPress

Become a Professional Trader with 0 Capital

KUALA LUMPUR,Malaysia,March 11,2025 -- Did you know? Starting now,anyone can become a professional trader without needing their own funds.

Breaking away from traditional proprietary trading firms (prop firms),M.T.I Prop empowers traders by providing substantial capital after they pass an evaluation—plus profit splits that outperform industry standards.

M.T.I Prop: No Capital Required,Unlimited Potential

Join theM.T.I Trading Challenge to win a Funded Account Worth up to $200,000. This challenge evaluates your trading skills. Pass the evaluation,and you'll receive a live trading account to grow profits with the firm's capital—all while facing far lower risks than traditional trading.

Why Choose M.T.I Prop?

Low-Cost Entry: Pay only the evaluation fee for a chance to manage large capital.

High Profit Potential: Earn up to 80% profit splits once funded.

Controlled Risk: Maximum loss limited to your evaluation fee—no hidden liabilities.

Zero Upfront Capital: Focus purely on passing the evaluation to start earning.

Launch Your Professional Trading Career with M.T.I Prop

Localized Malay Support,Seamless Communication


As a Malaysian-born proprietary trading firm,M.T.I provides rules,training,and customer support entirely in Malay. Clear guidelines and accessible resources help you master the evaluation process quickly.

Risk-Free Trading,High Rewards


Trade with up to $200,000 in funding and keep 80% of profits,while the platform covers all losses. Say goodbye to financial stress and hello to pure trading focus.

Industry-Leading Pass Rate


A streamlined one-step evaluation with a 30%+ pass rate—plus three free simulated challenges to practice before your official attempt.

Transparent Rules,Instant Profit Withdrawals


No hidden clauses. Withdraw earnings immediately after passing,with rapid bank transfers to ensure your profits land fast.

Free Expert Trading Course

Unlock a 1.5-hour premium video course upon registration. Learn proven strategies to ace the evaluation and accelerate your success.

What is a Prop Firm? Your Guide to the Evaluation Process

From trading tools to actual market insights,M.T.I Prop equips both beginners and seasoned traders to level up their skills—all while accessing a low-risk,high-reward opportunity.

Whether you're new to investing or a seasoned trader,M.T.I Prop's funding program offers a rare blend of risk management and growth potential.

Gain capital,sharpen your skills,and thrive under expert guidance—all in your native language.

Click here to learn more and sign up now.

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Diet Tips Daily